{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T20:28:22Z","timestamp":1775334502174,"version":"3.50.1"},"reference-count":44,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","funder":[{"name":"Mater Misericordiae University Hospital Gastrointestinal Research Fund","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>There are no robust noninvasive tools to predict long-term liver-related events in well-compensated cirrhosis. We assessed the performance of noninvasive fibrosis tools in predicting decompensation, hepatocellular carcinoma (HCC), and liver-related mortality (LRM) within a mixed aetiology Child Pugh A cirrhosis cohort.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Patients were followed in a single centre for 10 years. The primary outcome was decompensation (ascites, encephalopathy, or variceal bleeding). Secondary outcomes were HCC and LRM. All patients received baseline transient elastography for liver stiffness measurement (LSM) and blood tests to calculate Fibrosis-4 (FIB-4).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      In 114 patients, 31% decompensated during the follow-up period. 11% developed HCC. Increased LSM is associated with greater decompensation risk (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u20050.007). When controlling for FIB-4 and alcohol consumption, for each 1 kPa increase, the 10-year risk of decompensation increased by 2.2% [\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u20050.009, hazard ratio: 1.022, 95% confidence interval (CI): 1.01\u20131.04]. Ten-year risk of decompensation was 20% for LSM\u2005&lt;\u200521 kPa, 32% in the 21\u201335\u2005kPa group, and 47% in the \u226535\u2005kPa group (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u20050.019). After censoring for HCC, index LSM was associated with risk of death or liver transplant [odds ratio (OR): 1.029 (95% CI: 1\u20131.06)\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u20050.039]. FIB-4 is associated with HCC risk (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u20050.001) with an OR: 1.16 (95% CI: 1.01\u20131.32).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Ten-year risk of decompensation increased with increasing LSM in mixed aetiology compensated cirrhosis. LSM can be used to risk-stratify real-world patients, in order to reassure those at lowest risk and potentially focus resources on patients with higher scores and greatest decompensation risk.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/meg.0000000000003045","type":"journal-article","created":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T11:02:22Z","timestamp":1752836542000},"page":"54-62","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Transient elastography can stratify patients with Child Pugh A cirrhosis according to long-term risk of decompensation: a longitudinal cohort study"],"prefix":"10.1097","volume":"38","author":[{"given":"Paul","family":"Armstrong","sequence":"first","affiliation":[{"name":"The Liver Centre, Mater Misericordiae University Hospital"},{"name":"School of Medicine, University College Dublin"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aoife","family":"Moriarty","sequence":"additional","affiliation":[{"name":"The Liver Centre, Mater Misericordiae University Hospital"},{"name":"School of Medicine, University College Dublin"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Audrey","family":"Dillon","sequence":"additional","affiliation":[{"name":"School of Medicine, University College Dublin"},{"name":"National Liver Transplant Unit, St. Vincent\u2019s University Hospital, Dublin, Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zita","family":"Galvin","sequence":"additional","affiliation":[{"name":"School of Medicine, University College Dublin"},{"name":"National Liver Transplant Unit, St. Vincent\u2019s University Hospital, Dublin, Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Russell","sequence":"additional","affiliation":[{"name":"The Liver Centre, Mater Misericordiae University Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Stewart","sequence":"additional","affiliation":[{"name":"The Liver Centre, Mater Misericordiae University Hospital"},{"name":"School of Medicine, University College Dublin"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2025,7,18]]},"reference":[{"key":"R1-20251209","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.jhep.2017.10.020","article-title":"Clinical states of cirrhosis and competing risks.","volume":"68","author":"D\u2019Amico","year":"2018","journal-title":"J Hepatol"},{"key":"R2-20251209","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S2468-1253(19)30349-8","article-title":"The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017.","volume":"5","author":"Sepanlou","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"R3-20251209","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/s41575-023-00759-2","article-title":"Global epidemiology of cirrhosis - aetiology, trends and predictions.","volume":"20","author":"Huang","year":"2023","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R4-20251209","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.jhep.2021.12.022","article-title":"Baveno VII - Renewing consensus in portal hypertension.","volume":"76","author":"de Franchis","year":"2022","journal-title":"J Hepatol"},{"key":"R5-20251209","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.cld.2021.01.003","article-title":"Prevention of first decompensation in advanced chronic liver disease.","volume":"25","author":"Mandorfer","year":"2021","journal-title":"Clin Liver Dis"},{"key":"R6-20251209","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/nrgastro.2009.149","article-title":"The clinical use of HVPG measurements in chronic liver disease.","volume":"6","author":"Bosch","year":"2009","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R7-20251209","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1053\/j.gastro.2007.05.024","article-title":"Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis.","volume":"133","author":"Ripoll","year":"2007","journal-title":"Gastroenterology"},{"key":"R8-20251209","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1136\/gut.2010.216077","article-title":"Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease.","volume":"59","author":"McPherson","year":"2010","journal-title":"Gut"},{"key":"R9-20251209","doi-asserted-by":"crossref","first-page":"232","DOI":"10.14740\/gr1557","article-title":"Diagnostic accuracy of elastography and liver disease: a meta-analysis.","volume":"15","author":"Malik","year":"2022","journal-title":"Gastroenterology Res"},{"key":"R10-20251209","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.jhep.2013.10.027","article-title":"Detection of early portal hypertension with routine data and liver stiffness in patients with asymptomatic liver disease: a prospective study.","volume":"60","author":"Augustin","year":"2014","journal-title":"J Hepatol"},{"key":"R11-20251209","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.cgh.2020.06.045","article-title":"Monitoring occurrence of liver-related events and survival by transient elastography in patients with nonalcoholic fatty liver disease and compensated advanced chronic liver disease.","volume":"19","author":"Petta","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R12-20251209","doi-asserted-by":"crossref","first-page":"723","DOI":"10.14309\/ajg.0000000000000994","article-title":"Noninvasive diagnosis of portal hypertension in patients with compensated advanced chronic liver disease.","volume":"116","author":"Pons","year":"2021","journal-title":"Am J Gastroenterol"},{"key":"R13-20251209","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1097\/MEG.0000000000001224","article-title":"Transient elastography can stratify patients with Child-Pugh A cirrhosis according to risk of early decompensation.","volume":"30","author":"Dillon","year":"2018","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R14-20251209","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1111\/liv.12525","article-title":"Baseline and serial liver stiffness measurement in prediction of portal hypertension progression for patients with compensated cirrhosis.","volume":"34","author":"Wang","year":"2014","journal-title":"Liver Int"},{"key":"R15-20251209","doi-asserted-by":"crossref","first-page":"462","DOI":"10.3109\/00365521.2014.964758","article-title":"Liver stiffness and the prediction of clinically significant portal hypertension and portal hypertensive complications.","volume":"50","author":"Kitson","year":"2015","journal-title":"Scand J Gastroenterol"},{"key":"R16-20251209","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.jhep.2020.11.050","article-title":"Refining the Baveno VI elastography criteria for the definition of compensated advanced chronic liver disease.","volume":"74","author":"Papatheodoridi","year":"2021","journal-title":"J Hepatol"},{"key":"R17-20251209","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1053\/j.gastro.2013.06.057","article-title":"Simple noninvasive systems predict long-term outcomes of patients with nonalcoholic fatty liver disease.","volume":"145","author":"Angulo","year":"2013","journal-title":"Gastroenterology"},{"key":"R18-20251209","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0140-6736(21)01701-3","article-title":"The EASL-Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortality.","volume":"399","author":"Karlsen","year":"2022","journal-title":"Lancet"},{"key":"R19-20251209","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1136\/gut.2006.111302","article-title":"Reproducibility of transient elastography in the evaluation of liver fibrosis in patients with chronic liver disease.","volume":"56","author":"Fraquelli","year":"2007","journal-title":"Gut"},{"issue":"Suppl(1","key":"R20-20251209","doi-asserted-by":"crossref","first-page":"S100","DOI":"10.1016\/j.jhep.2004.11.015","article-title":"Assessment of the prognosis of cirrhosis: Child-Pugh versus MELD.","volume":"42","author":"Durand","year":"2005","journal-title":"J Hepatol"},{"key":"R21-20251209","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.jhep.2020.06.013","article-title":"The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiology.","volume":"73","author":"Trebicka","year":"2020","journal-title":"J Hepatol"},{"key":"R22-20251209","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1136\/gutjnl-2013-306627","article-title":"Hepatocellular carcinoma: clinical frontiers and perspectives.","volume":"63","author":"Bruix","year":"2014","journal-title":"Gut"},{"key":"R23-20251209","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1016\/j.jhep.2022.03.026","article-title":"Impact of non-invasive biomarkers on hepatology practice: past, present and future.","volume":"76","author":"Anstee","year":"2022","journal-title":"J Hepatol"},{"key":"R24-20251209","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.jhep.2015.05.022","article-title":"Expanding consensus in portal hypertension: report of the Baveno VI Consensus Workshop: stratifying risk and individualizing care for portal hypertension.","volume":"63","author":"De Franchis","year":"2015","journal-title":"J Hepatol"},{"key":"R25-20251209","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/ijn.12472","article-title":"Nurse-led hepatocellular carcinoma surveillance clinic provides an effective method of monitoring patients with cirrhosis.","volume":"22","author":"Nazareth","year":"2016","journal-title":"Int J Nurs Pract"},{"key":"R26-20251209","doi-asserted-by":"crossref","first-page":"e95776","DOI":"10.1371\/journal.pone.0095776","article-title":"Liver stiffness by transient elastography predicts liver-related complications and mortality in patients with chronic liver disease.","volume":"9","author":"Pang","year":"2014","journal-title":"PLoS One"},{"key":"R27-20251209","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/liv.14301","article-title":"Liver stiffness measurement predicts long\u2010term survival and complications in non\u2010alcoholic fatty liver disease.","volume":"40","author":"Shili\u2010Masmoudi","year":"2020","journal-title":"Liver Int"},{"key":"R28-20251209","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1002\/hep4.1841","article-title":"Fibrosis-4 index as an independent predictor of mortality and liver-related outcomes in NAFLD.","volume":"6","author":"Vieira Barbosa","year":"2022","journal-title":"Hepatol Commun"},{"key":"R29-20251209","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jhep.2005.10.013","article-title":"Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies.","volume":"44","author":"D\u2019Amico","year":"2006","journal-title":"J Hepatol"},{"key":"R30-20251209","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1111\/apt.12721","article-title":"Competing risks and prognostic stages of cirrhosis: a 25-year inception cohort study of 494 patients.","volume":"39","author":"D\u2019Amico","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"R31-20251209","doi-asserted-by":"crossref","first-page":"6868","DOI":"10.3748\/wjg.v23.i37.6868","article-title":"Hospital readmissions in decompensated cirrhotics: factors pointing toward a prevention strategy.","volume":"23","author":"Seraj","year":"2017","journal-title":"World J Gastroenterol"},{"key":"R32-20251209","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1056\/NEJMra1914900","article-title":"Acute-on-chronic liver failure.","volume":"382","author":"Arroyo","year":"2020","journal-title":"N Engl J Med"},{"key":"R33-20251209","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1016\/j.jhep.2020.12.005","article-title":"Transition to decompensation and acute-on-chronic liver failure: role of predisposing factors and precipitating events.","volume":"75","author":"Gustot","year":"2021","journal-title":"J Hepatol"},{"key":"R34-20251209","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.jhep.2022.11.013","article-title":"Low alcohol consumption influences outcomes in individuals with alcohol-related compensated cirrhosis in a French multicenter cohort.","volume":"78","author":"Louvet","year":"2023","journal-title":"J Hepatol"},{"key":"R35-20251209","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.jhep.2016.10.017","article-title":"Risk of cirrhosis-related complications in patients with advanced fibrosis following hepatitis C virus eradication.","volume":"66","author":"van der Meer","year":"2017","journal-title":"J Hepatol"},{"key":"R36-20251209","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.jhep.2020.11.021","article-title":"Clinical outcomes following DAA therapy in patients with HCV-related cirrhosis depend on disease severity.","volume":"74","author":"Krassenburg","year":"2021","journal-title":"J Hepatol"},{"key":"R37-20251209","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.jhep.2018.05.011","article-title":"Burden of liver disease in Europe: epidemiology and analysis of risk factors to identify prevention policies.","volume":"69","author":"Pimpin","year":"2018","journal-title":"J Hepatol"},{"key":"R38-20251209","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jhep.2018.03.019","article-title":"EASL clinical practice guidelines: management of hepatocellular carcinoma.","volume":"69","author":"Galle","year":"2018","journal-title":"J Hepatol"},{"key":"R39-20251209","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.cgh.2007.02.039","article-title":"Incidence and predictors of hepatocellular carcinoma in patients with cirrhosis.","volume":"5","author":"Ioannou","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R40-20251209","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/hep.29086","article-title":"AASLD guidelines for the treatment of hepatocellular carcinoma.","volume":"67","author":"Heimbach","year":"2018","journal-title":"Hepatology"},{"key":"R41-20251209","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1002\/hep.24121","article-title":"Risk assessment of hepatitis B virus\u2013related hepatocellular carcinoma development using liver stiffness measurement (FibroScan).","volume":"53","author":"Jung","year":"2011","journal-title":"Hepatology"},{"key":"R42-20251209","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1002\/hep.22870","article-title":"Prospective risk assessment for hepatocellular carcinoma development in patients with chronic hepatitis C by transient elastography.","volume":"49","author":"Masuzaki","year":"2009","journal-title":"Hepatology"},{"key":"R43-20251209","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/j.cgh.2013.07.034","article-title":"Liver stiffness is associated with risk of decompensation, liver cancer, and death in patients with chronic liver diseases: a systematic review and meta-analysis.","volume":"11","author":"Singh","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R44-20251209","doi-asserted-by":"crossref","first-page":"637","DOI":"10.3390\/cancers15030637","article-title":"Hepatocellular carcinoma in patients with nonalcoholic fatty liver disease: the prognostic role of liver stiffness measurement.","volume":"15","author":"Cerrito","year":"2023","journal-title":"Cancers (Basel)"}],"container-title":["European Journal of Gastroenterology &amp; Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MEG.0000000000003045","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T15:01:16Z","timestamp":1765292476000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MEG.0000000000003045"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,18]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/meg.0000000000003045","relation":{},"ISSN":["0954-691X","1473-5687"],"issn-type":[{"value":"0954-691X","type":"print"},{"value":"1473-5687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,18]]}}}